GSK Most Likely To Buy Pfizer's Consumer Business – Is It A Step In Wrong Direction?

UPDATE: SOON AFTER PUBLICATION OF THIS ARTICLE GSK ANNOUNCED IT HAD WITHDRAWN FROM THE BIDDING FOR PFIZER'S CONSUMER HEALTH BUSINESS. GSK looks likely to be the top bidder for Pfizer's consumer health business, with an offer announcement expected soon – but are more OTC products the answer to the UK major's longer-term sustainability and growth issues?